MedPath

WeChat in the control of blood glucose in diabetic patients

Not Applicable
Completed
Conditions
Diabetes
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN12251258
Lead Sponsor
Henan Provincial People's Hospital
Brief Summary

2018 results in https://www.ncbi.nlm.nih.gov/pubmed/30558051 (added 11/04/2019)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
120
Inclusion Criteria

1. They were diagnosed type 2 diabetes by physicians according to World Health Organization (WHO) criteria
2. Aged 18-60 years
3. Possessed a mobile phone
4. Consented to receive text messages
5. Have the ability to read text messages
6. Voluntarily to participate in this study

Exclusion Criteria

1. Diagnosed type 1 diabetes
2. Specific diabetes
3. history of serious diseases such as renal or hepatic insufficiency
4. Severe visual impairment
5. Psychiatric diseases
6. Other endocrine diseases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. HbA1c concentration is measured using the blood samples at six and 12 months<br> 2. Self-Efficacy is measured using the Diabetes Management Self-Efficacy Scale questionnaire at six and 12 months<br>
Secondary Outcome Measures
NameTimeMethod
<br> FPG and 2hPG is measured using blood samples at six and 12 months<br>
© Copyright 2025. All Rights Reserved by MedPath